Extended Data Table 2 Disposition of study treatment

From: The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer

  1. All percentages are calculated out of the number of participants who started study treatment. The treatment regimen included trastuzumab and chemotherapy in both groups.
Back to article page